Get started
Author

Feng‐Woei Tsay

H. pylori infection and extra-gastroduodenal diseases
2018 · Feng-Woei Tsay, Ping-I Hsu · Journal of Biomedical Science · 133
PDF
Helicobacter pylori Infection and the Risk of Gastric Malignancy
2007 · Ping-I Hsu, Kwok-Hung Lai, et al. · The American Journal of Gastroenterology · 109
Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria
2018 · Ping‐I Hsu, Chao‐Yu Pan, et al. · Helicobacter · 94
Randomized Controlled Trial Comparing 7-Day Triple, 10-Day Sequential, and 7-Day Concomitant Therapies for Helicobacter pylori Infection
2014 · Ping-I Hsu, Deng-Chyang Wu, et al. · Antimicrobial Agents and Chemotherapy · 75
A Prospective Randomized Trial of Esomeprazole- versus Pantoprazole-Based Triple Therapy for Helicobacter pylori Eradication
2005 · Ping-I Hsu, Kwok-Hung Lai, et al. · The American Journal of Gastroenterology · 67
Endoscopic papillary large balloon dilation alone without sphincterotomy for the treatment of large common bile duct stones
2011 · Hoi-Hung Chan, Kwok-Hung Lai, et al. · BMC Gastroenterology · 64
PDF
Helicobacter pylori Infection
2011 · Deng-Chyang Wu, Ping-I Hsu, et al. · Medicine · 53
Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures
2008 · P. I. Hsu, D. C. Wu, et al. · European Journal of Clinical Investigation · 53
α1-Antitrypsin Precursor in Gastric Juice Is a Novel Biomarker for Gastric Cancer and Ulcer
2007 · Ping-I Hsu, Chung-Hsuan Chen, et al. · Clinical Cancer Research · 52
Gastrointestinal Hemorrhage in Warfarin Anticoagulated Patients: Incidence, Risk Factor, Management, and Outcome
2014 · Wen-Chi Chen, Yan-Hua Chen, et al. · BioMed Research International · 47
PDF
Short‐term and long‐term impacts of Helicobacter pylori eradication with reverse hybrid therapy on the gut microbiota
2019 · Ping‐I Hsu, Chao‐Yu Pan, et al. · Journal of Gastroenterology and Hepatology · 46
PDF
A Comparison of Entecavir and Lamivudine for the Prophylaxis of Hepatitis B Virus Reactivation in Solid Tumor Patients Undergoing Systemic Cytotoxic Chemotherapy
2015 · Wen-Chi Chen, Jin-Shiung Cheng, et al. · PLoS ONE · 46
PDF
Equivalent Efficacies of Reverse Hybrid and Bismuth Quadruple Therapies in Eradication of Helicobacter pylori Infection in a Randomized Controlled Trial
2018 · Ping-I Hsu, Feng-Woei Tsay, et al. · Clinical Gastroenterology and Hepatology · 45
Ten‐Day Quadruple Therapy Comprising Proton‐Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin Achieves a High Eradication Rate for H elicobacter pylori Infection after Failure of Sequential Therapy
2013 · Ping‐I Hsu, Wen‐Chi Chen, et al. · Helicobacter · 44
A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance
2017 · Feng-Woei Tsay, Deng-Chyang Wu, et al. · Antimicrobial Agents and Chemotherapy · 37
Hepatic Arterial Infusion Chemotherapy for Patients with Huge Unresectable Hepatocellular Carcinoma
2014 · Wei-Lun Tsai, Kwok-Hung Lai, et al. · PLoS ONE · 36
Randomized comparison of two rescue therapies for Helicobacter pylori infection
2006 · D. C. Wu, P. I. Hsu, et al. · European Journal of Clinical Investigation · 36
The Compliance of Doctors with Viral Hepatitis B Screening and Antiviral Prophylaxis in Cancer Patients Receiving Cytotoxic Chemotherapy Using a Hospital-Based Screening Reminder System
2015 · Wei-Chih Sun, Ping-I Hsu, et al. · PLoS ONE · 35
PDF
A Randomized Controlled Study Comparing Reverse Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Infection
2015 · Ping-I Hsu, Sung-Shuo Kao, et al. · Medicine · 33
Upper gastrointestinal lesions in patients receiving clopidogrel anti-platelet therapy
2012 · Tzung-Jiun Tsai, Kwok-Hung Lai, et al. · Journal of the Formosan Medical Association · 31
Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial
2023 · Ping-I Hsu, Kuan-Yang Chen, et al. · The American Journal of Gastroenterology · 30
Equivalent efficacies of reverse hybrid and concomitant therapies in first‐line treatment of Helicobacter pylori infection
2020 · Ping‐I Hsu, Feng‐Woei Tsay, et al. · Journal of Gastroenterology and Hepatology · 30
PDF
Polymorphisms of death pathway genes FAS and FASL and risk of premalignant gastric lesions.
2008 · Ping-I Hsu, Pei-Jung Lu, et al. · PubMed · 30
Prevalence and risk factors of erosive esophagitis in Taiwan
2012 · Jian-Lin Ou, Chin-Chih Tu, et al. · Journal of the Chinese Medical Association · 26
Sequential therapy achieves a higher eradication rate than standard triple therapy in Taiwan
2011 · Feng‐Woei Tsay, Hui‐Hwa Tseng, et al. · Journal of Gastroenterology and Hepatology · 26
Works count: 87
Citation count: 1,627
H-index: 25
I10-index: 38
Year
Topic
Type